Cargando…
Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
In the past couple of decades, major efforts were made to increase reliability of metabolic assessments by magnetic resonance methods. Magnetic resonance spectroscopy (MRS) has been valuable for providing in vivo evidence and investigating biomarkers in neuropsychiatric disorders, namely schizophren...
Autores principales: | Duarte, João M. N., Xin, Lijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345729/ https://www.ncbi.nlm.nih.gov/pubmed/29616444 http://dx.doi.org/10.1007/s11064-018-2521-z |
Ejemplares similares
-
Glutamatergic dysfunction in Schizophrenia
por: Kruse, Andreas O., et al.
Publicado: (2022) -
Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study
por: Galińska-Skok, Beata, et al.
Publicado: (2018) -
T212. LEVELS OF GLUTAMATERGIC NEUROMETABOLITES IN PATIENTS WITH SEVERE TREATMENT-RESISTANT SCHIZOPHRENIA: A PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDY
por: Tarumi, Ryosuke, et al.
Publicado: (2020) -
Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington’s disease provides in vivo evidence for impaired energy metabolism
por: van den Bogaard, Simon J. A., et al.
Publicado: (2011) -
Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T
por: Taylor, Reggie, et al.
Publicado: (2017)